Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2025 04:13 ET | Source: Research and Markets

Graft Versus Host Disease (GvHD) Treatment Markets and Companies: Global Strategic Business Report 2025-2030

Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market...
April 18, 2025 04:03 ET | Source: Research and Markets

Global GVHD Treatment Market Set for 7.34% CAGR Growth Amid Rising Transplant Procedures

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
December 10, 2024 09:45 ET | Source: Research and Markets

Graft Versus Host Disease (GvHD) Treatment Market Outlook, 2024-2028 & 2033 - Revenue Shares for Corticosteroids, Monoclonal Antibodies, Immunosuppressants and Other Products

Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This GvHD treatment...
June 26, 2024 09:34 ET | Source: Research and Markets

Acute Graft-Versus-Host Disease Pipeline Research 2024 Featuring MaaT Pharma, Medac, CSL Behring, Humanigen, Ironwood Pharmaceuticals, ReAlta Life Sciences, Roche, and Incyte

Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Acute Graft-Versus-Host Disease - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Acute...
May 28, 2024 06:38 ET | Source: Research and Markets

Graft versus Host Disease (GvHD) Pipeline Insights Report, 2024: Reveals 60+ Companies Engaged in Advancing 65+ Pipeline Drugs

Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Graft versus host disease - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. This report offers an in-depth look...
April 12, 2024 10:03 ET | Source: Research and Markets

Graft Versus Host Disease (GvHD) Treatment Market Analysis, 2018-2023 and 2024-2030: Corticosteroids, Hospitals, and North America Will Dominate During the Forecast Period

Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ...
January 26, 2024 09:10 ET | Source: Research and Markets

Global Graft Versus Host Disease (GvHD) Treatment Market Forecast, 2028: High Treatment Costs and Infection Risks Prompt Focus on Predictive Biomarkers and Balanced Immunosuppression in Healthcare

Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
January 24, 2024 12:56 ET | Source: Research and Markets

Graft vs. Host Disease Comprehensive 2032 Forecast Reveals Escalating Patient Populations in the 7MM

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This detailed analysis...
September 13, 2023 06:54 ET | Source: Research and Markets

Global Graft Versus Host Disease Treatment Market 2023-2030: Monoclonal Antibodies Lead Surge in Graft Versus Host Disease Treatment Market, Monitored by Comprehensive Vendor Analysis

Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Graft Versus Host Disease Treatment Market by Disease Type, Product, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
August 30, 2022 05:28 ET | Source: Research and Markets

Global Graft Versus Host Disease Treatment Market 2022-2027:Annual Growth of 9.21% Driven by Key Players GlaxoSmithKline, Pfizer, Merck

Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Global Graft Versus Host Disease Treatment Market (2022-2027) by Disease Type, Product, Geography, Competitive Analysis and the Impact of Covid-19 with...